1. Home
  2. AZTR vs QCLS Comparison

AZTR vs QCLS Comparison

Compare AZTR & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

BUY

Current Price

$0.12

Market Cap

7.9M

Sector

Health Care

ML Signal

BUY

Logo Q/C Technologies Inc.

QCLS

Q/C Technologies Inc.

HOLD

Current Price

$0.58

Market Cap

7.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
QCLS
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9M
7.1M
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
AZTR
QCLS
Price
$0.12
$0.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
628.4K
★ 6.1M
Earning Date
11-11-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
5.06
★ 22.33
EPS
★ N/A
N/A
Revenue
N/A
★ $3,929,527.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 32.71
52 Week Low
$0.10
$0.42
52 Week High
$1.09
$11.80

Technical Indicators

Market Signals
Indicator
AZTR
QCLS
Relative Strength Index (RSI) 31.49 27.23
Support Level $0.10 $0.42
Resistance Level $0.15 $1.18
Average True Range (ATR) 0.01 0.10
MACD -0.00 0.04
Stochastic Oscillator 5.06 0.91

Price Performance

Historical Comparison
AZTR
QCLS

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About QCLS Q/C Technologies Inc.

Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

Share on Social Networks: